Nanocellect Biomedical Inc is categorized under Research and Development Laboratories in San Diego, CA and active since 2009.
Nanocellect Biomedical Inc was established in 2009, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Research and Development Laboratories business, which does work in the B2B market, and is classified as a Research and Development Laboratories, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Jose Morachis at the company’s single location by writing to 7770 Regents Road 113390, San Diego, California CA 92122 or by phoning (858) 356-5965. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Nanocellect Biomedical Inc |
| Contact Person: | Jose Morachis |
| Address: | 7770 Regents Road 113390, San Diego, California 92122 |
| Phone Number: | (858) 356-5965 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2009 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Research and Development Laboratories |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Nanocellect Biomedical Inc was started in 2009 to provide professional Research and Development Laboratories under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Jose Morachis for inquiries that concern Nanocellect Biomedical Inc by calling the company number (858) 356-5965, as your correspondence is most welcome. Additionally, the physical location of the single location of Nanocellect Biomedical Inc can be found at the coordinates 32.863258,-117.222777 as well as the street address 7770 Regents Road 113390 in San Diego, California 92122.
For its online presence, you may visit Nanocellect Biomedical Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.